Document is current
Any future updates will be listed below
-
Authors
Edahiro, Yoko
- License Information
-
More Information
Article History
Received: 1 March 2022
Revised: 20 March 2022
Accepted: 21 March 2022
First Online: 8 April 2022
Declarations
:
: The author received grants from PharmaEssentia Japan K.K. and Meiji Seika Pharma Co., Ltd., received honorary funds from PharmaEssentia Japan K.K. and is a member of the advisory boards of PharmaEssentia Japan K.K. and Novartis Pharma K.K.
